Real-time enrollment status for this cirrhosis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 1:25 AM UTC
| NCT Number | NCT06528314 |
| Recruiting Status | Recruiting |
| Condition | Cirrhosis |
| Phase | PHASE3 |
| Target Enrollment | 2,150 participants |
| Active Locations | 169 sites in the US |
| Sponsor | Akero Therapeutics, Inc |
| Last Updated on CT.gov | July 16, 2026 (2 days ago) |
As of July 18, 2026: Clinical trial NCT06528314 is currently recruiting participants. This phase3 study for cirrhosis is actively seeking new participants at 169 locations across the United States. The study is sponsored by Akero Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06528314 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 169 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06528314 was last updated 2 days ago (July 16, 2026). HelloStudys verifies this status automatically.